#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Pleomorphic liposarcoma Leiomyosarcoma recurrent Acute myeloid leukaemia refractory Hepatitis D Hereditary optic atrophy Pyruvate dehydrogenase complex deficiency Cryoglobulinaemia Cholestatic pruritus Lymphoma Friedreich's ataxia Primary adrenal insufficiency Nephrotic syndrome Renal cancer metastatic Burkitt's lymphoma More trials…

    Learn about Rare Diseases

    Nephroblastoma – Treatment Glomerulonephritis membranoproliferative Chronic granulomatous disease – Diagnostics Antisynthetase syndrome – Trials in Disease Friedreich’s ataxia Primary immunodeficiency syndrome – Treatment Breast angiosarcoma metastatic – Trials in Disease Alagille syndrome Ewing’s sarcoma metastatic – Treatment Haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AVTX-009 Triglycerides, Medium Chain Calcium Folinate PICLIDENOSON Osteodex Phleum Pratense Acetylcysteine Amide Indacaterol Seralutinib Ly3298176 BI-1607 Famotidine Lufepirsen Pertechnetate (99Mtc) Sodium Ethambutol Hydrochloride Ads-015 Ep262 Fluorouracil Deferiprone Mitoxantrone Hydrochloride More therapies…

    Learn about Your Condition

    Lupus nephritis Fragile X syndrome Breast cancer in situ Myositis Cutaneous T-cell lymphoma Adenocarcinoma Barrett's oesophagus Mental disorder Skin wrinkling Vaginal cancer Erythema Herpes simplex Paedophilia Renal cancer stage IV Ichthyosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Study of cabergoline compared to dienogest and ethinylestradiol for reducing endometriosis symptoms and lesion size in women with confirmed endometriosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Cabergoline
    • Ethinylestradiol
    Spain

  • Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Menopausal symptoms
    Investigated Drugs:
    • Estradiol
    • NORETHISTERONE ACETATE
    • Progesterone, Micronised
    Sweden

  • Study Comparing Intranasal Nafarelin and Subcutaneous Triptorelin for Final Egg Maturation in Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Nafarelin
    • Triptorelin
    Spain

  • Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrophic vulvovaginitis
    Investigated Drugs:
    • Tamoxifen Citrate
    Sweden

  • Study on Antibiotic Combination of Ceftriaxone, Clarithromycin, and Metronidazole for Pregnant Women with Threatened Miscarriage and Intact Membranes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Abortion threatened
    Investigated Drugs:
    • Clarithromycin
    • Ceftriaxone Sodium
    • Metronidazole
    France

  • Study on Certolizumab for Women with Unexplained Recurrent Implantation Failure

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Implantation complication
    Investigated Drugs:
    • Certolizumab Pegol
    • Sodium Chloride
    France
Previous Page
1 … 19 20 21 22 23 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!